Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

452
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
452
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

216
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
216
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

477
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
477
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

254
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
254
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

340
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
340
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

478
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
478

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions of death, dying and the body in Vietnamese culture: A qualitative exploration from a study examining the potentials of minimally invasive tissue sampling in Vietnam.

SSM. Qualitative research in health·2026
Same author

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.

The Journal of infection·2026
Same author

Correlation Between Renal Biomarkers, Glomerular Filtration Rate, and Meropenem Clearance in Pediatric Septic Shock.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Late Recognition of Glucose-6-Phosphate Dehydrogenase Deficiency in a 70-Year-Old Man: A Case Report.

Cureus·2026
Same author

The cause, treatment and outcome of hyponatraemia associated with tuberculous meningitis: An observational study nested within two clinical trials of corticosteroids.

The Journal of infection·2026
Same author

Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial.

EClinicalMedicine·2026

Related Experiment Video

Updated: Sep 26, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

363

Tuberculous meningitis: progress and remaining questions.

Julie Huynh1, Joseph Donovan1, Nguyen Hoan Phu2

  • 1Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK; Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam.

The Lancet. Neurology
|April 16, 2022
PubMed
Summary
This summary is machine-generated.

Tuberculous meningitis diagnosis and treatment remain challenging. Emerging molecular technologies and ongoing clinical trials offer hope for improved diagnostic and therapeutic strategies for this severe brain infection.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

617

Related Experiment Videos

Last Updated: Sep 26, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

363
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

617

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Molecular Biology

Background:

  • Tuberculous meningitis (TBM) is a severe Mycobacterium tuberculosis infection of the brain.
  • Diagnosis and treatment of TBM are difficult, leading to poor outcomes.
  • New molecular technologies reveal pathways linked to TBM severity.

Purpose of the Study:

  • To explore novel diagnostic and therapeutic targets for TBM.
  • To evaluate advancements in TBM diagnostics and treatment strategies.
  • To leverage multi-omics data for understanding TBM pathogenesis.

Main Methods:

  • Utilizing next-generation sequencing and multi-omics (transcriptome, proteome, metabolome).
  • Assessing the performance of GeneXpert MTB/RIF Ultra assay on cerebrospinal fluid (CSF).
  • Analyzing data from ongoing large-scale Phase 3 clinical trials.

Main Results:

  • GeneXpert MTB/RIF Ultra assay shows ~70% sensitivity for TBM diagnosis in CSF.
  • Small trials suggest improved outcomes with higher rifampicin doses or added drugs (linezolid, fluoroquinolones).
  • Adjunctive therapies like aspirin and corticosteroids show potential benefits.

Conclusions:

  • Multi-omics approaches are identifying new targets for TBM diagnosis and therapy.
  • Ongoing large clinical trials are crucial for optimizing TBM management.
  • Further research is needed to improve diagnostic accuracy and treatment efficacy for TBM.